Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06911177
NA

Yeast Mannans and Stool Frequency

Sponsor: University of Florida

View on ClinicalTrials.gov

Summary

Findings from an open-label pilot study of 20 adults suggested that supplementation with 15 g/day of yeast mannans was highly tolerable and demonstrated specific modulation of the microbiota and increased stool frequency in a subset of subjects reporting ≤1 stool per day at baseline. The primary aim of this randomized, double-blind, controlled trial is to determine if yeast mannan supplementation at 12 g/day will increase stool frequency in generally healthy adults reporting ≤1 stool per day. Secondary aims will determine the effect of yeast mannans on intestinal transit time, gastrointestinal symptoms, fecal microbiota composition, and urinary and fecal metabolomics.

Official title: Efficacy of Yeast Mannan Supplementation on Increasing Stool Frequency in Generally Healthy Adults: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2025-07-17

Completion Date

2026-06-30

Last Updated

2026-02-04

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Yeast mannan

Yeast cell wall fraction of manno-oligosaccharides and mannoproteins supplemented at 12 g/day.

DIETARY_SUPPLEMENT

Control (placebo)

A supplement containing yeast protein, yeast extract, and maltodextrin, provided at 12 g/day.

Locations (1)

Department of Food Science and Human Nutrition

Gainesville, Florida, United States